A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2
NCT05214690 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2022-01-31
Summary
Randomized, Open-label, Oral, Single-dose, two-Sequence, four-Period, crossover study
Conditions
- Osteoarthritis
- Rheumatoid Arthritis
- Back Pain
- Acute Upper Respiratory Tract Infection
Interventions
- DRUG
-
DW1809-T2
pelubiprofen 25mg
- DRUG
-
DW1809-1
pelubiprofen 30mg (PELUBI tab.)
Sponsors & Collaborators
-
Daewon Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-13
- Primary Completion
- 2020-09-08
- Completion
- 2020-09-08
Countries
- South Korea
Study Locations
More Related Trials
-
Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
NCT06318845 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
NCT05149274 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects
NCT07239453 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Pharmacokinetics and Safety Following Administration of DWP16001
NCT05414591 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
NCT06109259 ·Status: RECRUITING ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
NCT05739877 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers
NCT06119945 ·Status: RECRUITING ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
NCT07260851 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects
NCT03016494 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects
NCT02952547 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
NCT06010589 ·Status: UNKNOWN ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State
NCT05098886 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.
NCT05823883 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers
NCT03016520 ·Status: UNKNOWN ·Phase: PHASE1
-
A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
NCT05192395 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R
NCT06147908 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers
NCT04159961 ·Status: COMPLETED ·Phase: PHASE1
-
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT07144176 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
NCT04946903 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)
NCT04167267 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
NCT07267221 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers
NCT05132049 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
NCT06355349 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
NCT05463497 ·Status: COMPLETED ·Phase: PHASE1
-
PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
NCT07256600 ·Status: COMPLETED ·Phase: PHASE1